Aneratrigine

N/A

Report date: 2025/12/22 10:41:32
NME

Base Information

Drug NameAneratrigine
Drug Alias NameiN1011-N17DWP-17061
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type IX alpha subunit blockers
TargetsSodium channel protein type IX alpha subunit
Therapy Area/IndicationsChronic PainPainNeuralgia, Postherpetic +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaSouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDaewoong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesiN Therapeutics Co LtdDaewoong Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsChronic PainPainNeuralgia, Postherpetic +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A